Elucidating epigenetic mechanisms of cellular cadmium toxicity
阐明细胞镉毒性的表观遗传机制
基本信息
- 批准号:10266094
- 负责人:
- 金额:$ 7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-21 至 2022-04-08
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcuteAffectApoptosisArtsAutomobile DrivingBiologicalBromodomainCadmiumCell DeathCell SurvivalCellsChemicalsChromatinClinicalConsumptionCultured CellsDNADataDefectDrug TargetingEnvironmental PollutantsEpigenetic ProcessEpithelial CellsExcretory functionExposure toFibroblastsFood ContaminationFood SupplyFoundationsGene ExpressionGene Expression ProfileGenerationsGenesGoalsHalf-LifeHistologicHistone AcetylationHistone Deacetylase InhibitorHistonesHumanImpairmentIndividualIndustrializationInflammationKidneyLinkLiverLungLysineMammalian CellMeasuresMedicalMethylationMissionMitochondriaMolecularMusOccupationalOrganOxidation-ReductionPancreasPathogenicityPathologicPathway interactionsPost-Translational Protein ProcessingPublic HealthReactive Oxygen SpeciesRenal functionResistanceRespirationRiskSerum MarkersSiteStressTechniquesTestingTestisTissuesToxic effectToxicologyTubular formationUnited States National Institutes of HealthVorinostatWorkabsorptionbasebonecarcinogenesiscell injurycellular targetingdrinking waterhigh throughput screeninghistone modificationimprovedin vivoinhibitor/antagonistinnovationinsightinterestkidney dysfunctionmitochondrial metabolismnephrotoxicitynew therapeutic targetnovelpollutantprogramsprotective effectreproductiveresponsescreeningsmall moleculetargeted agenttissue injurytranscriptome sequencingtranscriptomicsurinary
项目摘要
Abstract
Cadmium (Cd) is a widespread environmental pollutant that affects millions of individuals worldwide. Cd
exposure in humans occurs most often through Cd’s many industrial applications, or consumption of
contaminated food. Due to its extremely extended biological half-life, Cd persists for decades in tissues, primarily
in the liver and kidneys. Cd exerts numerous deleterious effects, including bone, reproductive,
neurodevelopmental, and pulmonary toxicities, and carcinogenesis. The kidneys are the major target of Cd
toxicity, particularly the proximal tubular epithelial cells, injury to which hampers tubular reabsorption. Despite
the many sequelae associated with Cd exposure in humans, specific molecular mechanisms of Cd toxicity are
poorly understood, and no specific therapies exist to mitigate the effects of Cd exposure. Via unbiased high-
throughput screening, we identified a previously unknown ability of multiple chemically distinct histone
deacetylase inhibitors (HDACi) and Bromodomain and Extra-Terminal motif inhibitors (BETi) to rescue acute
cellular Cd toxicity. The long-term goal of these studies is to elucidate novel aspects of the cellular and
molecular mechanisms of Cd toxicity. The objectives of this application are: i) to evaluate changes in gene
expression and chromatin acetylation (Ac) occurring in response to Cd exposure in cultured cells and the kidney,
and their potential rescue by HDACi or BETi treatment; and ii) to test the ability of HDACi and BETi to mitigate
Cd induced nephrotoxicity. The central hypothesis of this application is that the interplay between histone Ac
and mitochondrial metabolism represents a key functional target of Cd toxicity in mammalian cells. The rationale
for this application is our novel foundational data demonstrating that Cd exposure induces a reduction in
mitochondrial function and histone Ac. Crucially, treatment with HDACi and BETi rescue Cd-induced defects in
mitochondrial respiration, metabolite levels, and cell viability. These findings implying that histone Ac and
mitochondrial function are important functional cellular targets of Cd. The work will take place in the context of
two Specific Aims. First, via RNA-seq and chromatin profiling, functionally important genes and pathways
targeted by Cd, and rescued by an HDACi and a BETi, will be identified in cultured fibroblasts. Second, rescue
of Cd-induced nephrotoxicity by an HDACi and a BETi will be evaluated in vivo in mice. We will compare the
gene expression signatures of Cd-exposed kidney and fibroblasts, to identify core gene expression programs
driving Cd toxicity, particularly focusing on those rescued by HDACi and BETi. The approach is innovative, in
that mechanistic links between epigenetic alterations induced by Cd and its biological effects have yet to be
conclusively established, and the use of small molecules directed against histone Ac or epigenetic perturbations
more generally as treatments for Cd toxicity has not previously been described. The work is significant, since
there is an unmet need for improved, mechanism-treatments for Cd toxicity. These studies may establish histone
Ac as a novel therapeutic target for Cd toxicity.
抽象的
镉 (Cd) 是一种广泛存在的环境污染物,影响着全世界数百万人。
人类接触镉最常发生在许多工业应用中,或者消费
由于镉的生物半衰期极长,它会在组织中(主要是组织)持续存在数十年。
镉对肝脏和肾脏产生许多有害影响,包括骨骼、生殖、
神经发育、肺部毒性和致癌作用 肾脏是镉的主要靶标。
毒性,特别是近端肾小管上皮细胞的损伤,阻碍了肾小管的重吸收。
人类与镉暴露相关的许多后遗症,镉毒性的具体分子机制是
人们对此知之甚少,并且没有特定的疗法可以通过无偏见的高剂量来减轻镉暴露的影响。
通过通量筛选,我们发现了多种化学上不同的组蛋白的先前未知的能力
脱乙酰酶抑制剂(HDACi)和布罗莫结构域和末端基序抑制剂(BETi)可挽救急性
这些研究的长期目标是阐明细胞和细胞毒性的新方面。
镉毒性的分子机制 本申请的目的是: i) 评估基因的变化。
培养细胞和肾脏中镉暴露引起的表达和染色质乙酰化 (Ac),
以及 HDACi 或 BETi 治疗的潜在救援作用;以及 ii) 测试 HDACi 和 BETi 缓解的能力;
Cd 诱导的肾毒性本申请的中心假设是组蛋白 Ac 之间的相互作用。
线粒体代谢是哺乳动物细胞中镉毒性的一个关键功能靶点。
对于该应用,我们的新颖基础数据表明,镉暴露会导致
线粒体功能和组蛋白 Ac 至关重要的是,HDACi 和 BETi 治疗可挽救 Cd 诱导的缺陷。
这些发现表明组蛋白 Ac 和细胞活力。
线粒体功能是 Cd 的重要功能性细胞靶标。这项工作将在 Cd 的背景下进行。
两个具体目标,首先,通过 RNA 测序和染色质分析,发现功能重要的基因和通路。
Cd 靶向并由 HDACi 和 BETi 拯救,将在培养的成纤维细胞中进行鉴定。
我们将在小鼠体内评估 HDACi 和 BETi 引起的 Cd 肾毒性。
暴露于镉的肾脏和成纤维细胞的基因表达特征,以确定核心基因表达程序
驱动 Cd 毒性,特别关注那些由 HDACi 和 BETi 拯救的人。该方法是创新的。
Cd 引起的表观遗传改变与其生物效应之间的机制联系尚未确定
最终确定,并使用针对组蛋白 Ac 或表观遗传扰动的小分子
更广泛地说,因为此前尚未描述过镉毒性的治疗方法,因此这项工作意义重大。
对镉毒性的改进机制治疗的需求尚未得到满足,这些研究可能会确定组蛋白。
Ac 作为 Cd 毒性的新型治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Benner Lombard其他文献
David Benner Lombard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Benner Lombard', 18)}}的其他基金
SIRT5 inhibitors and degraders as novel treatments for Ewing sarcoma
SIRT5 抑制剂和降解剂作为尤文肉瘤的新型治疗方法
- 批准号:
10739630 - 财政年份:2023
- 资助金额:
$ 7万 - 项目类别:
SIRT5 inhibitors and degraders as novel treatments for Ewing sarcoma
SIRT5 抑制剂和降解剂作为尤文肉瘤的新型治疗方法
- 批准号:
10385995 - 财政年份:2022
- 资助金额:
$ 7万 - 项目类别:
Targeting the longevity regulator PAPP-A with small molecule inhibitors
使用小分子抑制剂靶向寿命调节剂 PAPP-A
- 批准号:
10464342 - 财政年份:2022
- 资助金额:
$ 7万 - 项目类别:
Elucidating epigenetic mechanisms of cellular cadmium toxicity
阐明细胞镉毒性的表观遗传机制
- 批准号:
10669969 - 财政年份:2022
- 资助金额:
$ 7万 - 项目类别:
Targeting the longevity regulator PAPP-A with small molecule inhibitors
使用小分子抑制剂靶向寿命调节剂 PAPP-A
- 批准号:
10668304 - 财政年份:2022
- 资助金额:
$ 7万 - 项目类别:
Mechanisms of age-associated cardiac heterochromatin dysfunction
年龄相关心脏异染色质功能障碍的机制
- 批准号:
9165389 - 财政年份:2016
- 资助金额:
$ 7万 - 项目类别:
Mechanisms of tumor suppression by the chromatin deacetylase SIRT6
染色质脱乙酰酶 SIRT6 抑制肿瘤的机制
- 批准号:
8689985 - 财政年份:2013
- 资助金额:
$ 7万 - 项目类别:
Mechanisms of tumor suppression by the chromatin deacetylase SIRT6
染色质脱乙酰酶 SIRT6 抑制肿瘤的机制
- 批准号:
8564971 - 财政年份:2013
- 资助金额:
$ 7万 - 项目类别:
Novel mechanisms of mitochondrial regulation by sirtuin deacetylases
Sirtuin 脱乙酰酶调节线粒体的新机制
- 批准号:
8826143 - 财政年份:2012
- 资助金额:
$ 7万 - 项目类别:
Novel mechanisms of mitochondrial regulation by sirtuin deacetylases
Sirtuin 脱乙酰酶调节线粒体的新机制
- 批准号:
8270726 - 财政年份:2012
- 资助金额:
$ 7万 - 项目类别:
相似国自然基金
组蛋白乙酰化修饰介导Hint2调控NETosis对急性肝衰竭的影响及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于非组蛋白乙酰化修饰探讨GSK3β/ULK1通路调控线粒体自噬对急性肝衰竭能量代谢的影响
- 批准号:82070609
- 批准年份:2020
- 资助金额:54 万元
- 项目类别:面上项目
组蛋白去乙酰化酶介导的自噬-NLRP3炎症小体轴对急性肝衰竭细胞焦亡途径的影响
- 批准号:81870413
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
自噬应激对脊髓急性损伤和修复的影响及其调控机制的研究
- 批准号:81301059
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
蛋白去乙酰化酶SIRT1对LPS诱导的肺泡巨噬细胞自噬及急性肺损伤中炎症的影响及其机制
- 批准号:81300056
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
帕比司他治疗成人镰状细胞病的 I 期研究:招募和保留的新方法
- 批准号:
10420453 - 财政年份:2023
- 资助金额:
$ 7万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 7万 - 项目类别:
Acetyl CoA Carboxylase in the Metabolic Control of Inflammation
乙酰辅酶A羧化酶在炎症代谢控制中的作用
- 批准号:
10660439 - 财政年份:2023
- 资助金额:
$ 7万 - 项目类别:
Targeting gut brain-signaling to reduce cocaine seeking behaviors
针对肠道大脑信号传导以减少可卡因寻求行为
- 批准号:
10733638 - 财政年份:2023
- 资助金额:
$ 7万 - 项目类别:
Epigenetic-metabolic aspects of alcohol use disorder and early developmental alcohol exposure
酒精使用障碍和早期发育酒精暴露的表观遗传代谢方面
- 批准号:
10745787 - 财政年份:2023
- 资助金额:
$ 7万 - 项目类别: